2024
|
Invention
|
Compositions and methods for the inhibition of natural killer cells. The present disclosure relat... |
|
Invention
|
Compositions and methods for inhibition of ras. Provided herein are compounds, or salts, esters, ... |
2023
|
Invention
|
Compositions and methods for inhibition of kras. Provided herein are compounds, or salts, esters,... |
|
Invention
|
Compounds having a t-structure formed by at least four cycles for use in the treatment of cancer ... |
|
Invention
|
Kras inhibitors. Provided herein are compounds, or salts, esters, tautomers, prodrugs, zwitterion... |
2022
|
Invention
|
Compositions and methods for inhibition of ras.
Provided herein are compounds, or salts, esters,... |
|
Invention
|
Compositions and methods for inhibiting kras.
Provided herein are compounds of formula (I) and (... |
|
Invention
|
Compositions and methods for inhibition of ras. Provided herein are compounds of formula (I) and ... |
2020
|
Invention
|
K-ras modulators. Provided herein, inter alia, are methods and compounds for inhibiting K-Ras and... |
2019
|
Invention
|
K-ras modulators with a vinyl sulfone moiety. Provided herein are compounds comprising a vinyl su... |
|
Invention
|
K-ras modulators with a vinyl sulfonamide moiety. Provided herein are compounds comprising a viny... |
|
Invention
|
K-ras modulators with a cyanoacrylamide moiety. Provided herein are compounds comprising a cyanoa... |
2018
|
Invention
|
K-ras modulators. Provided herein are the K-Ras inhibitors of the formulae:
Also provided are c... |
|
Invention
|
K-ras modulators. Provided herein, inter alia, are methods and compounds for modulating K-Ras tre... |
2016
|
Invention
|
K-ras modulators. Provided herein, inter alia, are methods and compounds of formula (I) for inhib... |
2011
|
Invention
|
Block alignment for microtomes. Systems and methods described herein for aligning a block in a mi... |